Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I First-in-Human, Dose Finding, Open Label Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)

The purpose of this phase I trial is to determine the safety of NP-G2-044 among patients with solid tumors, including pancreatic cancer.

NCT#: NCT03199586
Study ID: NP-G2-044-P1-01
Trial Phase: Phase I

Trial Sponsor: Novita Pharmaceuticals
Therapies Used in This Trial: NP-G2-044

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Back to Trial Search